about
Tubulin-interactive natural products as anticancer agentsIntravital FRET imaging of tumor cell viability and mitosis during chemotherapy[A meta-analysis of platinum plus docetaxel or vinorelbine in the first-line treatment of advanced non-small cell lung cancer].A phase I clinical trial of dose escalation of lobaplatin in combination with fixed-dose docetaxel for the treatment of human solid tumours that had progressed following chemotherapyImmunomodulatory Protein from Ganoderma microsporum Induces Pro-Death Autophagy through Akt-mTOR-p70S6K Pathway Inhibition in Multidrug Resistant Lung Cancer Cells.Phase II trial of capecitabine combined with docetaxel in previously treated patients with non-small cell lung cancer: A randomized controlled study.The shape of things to come: structural and synthetic studies of taxol and related compoundsDehydroandrographolide, an iNOS inhibitor, extracted from Andrographis paniculata (Burm.f.) Nees, induces autophagy in human oral cancer cells.Docetaxel-based induction therapy prior to radiotherapy with or without docetaxel for non-small-cell lung cancer.Overview of major classes of plant-derived anticancer drugsPolyphyllin G induce apoptosis and autophagy in human nasopharyngeal cancer cells by modulation of AKT and mitogen-activated protein kinase pathways in vitro and in vivo.Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect.The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapy.Successful treatment of pulmonary metastasis and local recurrence of angiosarcoma with docetaxel.DKK4-knockdown enhances chemosensitivity of A549/DTX cells to docetaxel.Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors.FoxM1 inhibition enhances chemosensitivity of docetaxel-resistant A549 cells to docetaxel via activation of JNK/mitochondrial pathway.Fibronectin protects lung cancer cells against docetaxel-induced apoptosis by promoting Src and caspase-8 phosphorylation.
P2860
Q24650163-F58B289A-124A-42B2-9BC2-4216552E03C6Q27319918-E9CB2B29-5B88-4B17-8398-F01971B9F941Q33414806-749FA297-1752-4E25-8840-2223047F70FBQ34583261-FFA469F1-AD51-42D5-85DD-7FF912A0AA8FQ35577645-14123025-59C7-4100-B773-4B7FFC5924A3Q35995493-1E8B94BC-3F6E-4D0D-A6FD-63AD3EF68483Q35996314-A50594C0-2B70-465A-9A8F-83E0C9211F16Q36544433-AAC34155-CEC1-4562-997C-D2BA4512FD46Q36614143-9A82429F-6865-4A90-A8B9-414C46FB8AD0Q36735506-296F809F-C64A-4FE6-82FA-E8641B1EB604Q37688524-6E684627-D184-40A1-9F21-EC21BE614069Q39409268-DE7D93E2-EC9A-4862-8B93-1FAB2ABA2E3FQ43742480-A26B5AB2-273E-4044-96B7-D962A64E984CQ44929199-4C5BEE89-2E30-4A72-A194-A517CC629B2FQ47752736-0CE004FB-41D6-419A-8A16-ED519F9145C6Q50736135-CC1EEF39-B402-4C42-A606-53ECAADBD749Q51573165-F54AD705-B55A-4201-A8AA-4678E5D0CDB3Q51611913-1C6663BE-0F9A-4F4E-B36A-1EB1D2922BA4
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Docetaxel in non-small cell lung cancer: a review.
@ast
Docetaxel in non-small cell lung cancer: a review.
@en
type
label
Docetaxel in non-small cell lung cancer: a review.
@ast
Docetaxel in non-small cell lung cancer: a review.
@en
prefLabel
Docetaxel in non-small cell lung cancer: a review.
@ast
Docetaxel in non-small cell lung cancer: a review.
@en
P2093
P2860
P356
P1476
Docetaxel in non-small cell lung cancer: a review.
@en
P2093
Angela M Davies
Philip C Mack
Primo N Lara
P2860
P304
P356
10.1517/14656566.4.4.553
P407
P577
2003-04-01T00:00:00Z